Month: September 2019 (Page 22)

Joy A. Strand, the executive director of the Maryland Medical Cannabis Commission, is stepping down, effective Oct. 1. Strand, a health-care executive, led the commission for almost two years. The commission oversees the regulations and implementation of the state’s medical marijuana program. No reason was given for Stand’s resignation, The BaltimoreContinue Reading

The Ohio medical board dealt a blow to the state’s medical cannabis industry when it rejected petitions seeking to add anxiety and autism spectrum disorders as qualifying conditions. The board voted down those additions Wednesday after a Medical Board committee last month backpedaled on an earlier recommendation to add the conditions.Continue Reading

Myrcene, also found in hops, is one of the most abundantly found terpenes in the world of cannabis. The post Canadian Cannabis Strains for People Who Love Myrcene appeared first on Leafly. Read More: Canadian Cannabis Strains for People Who Love MyrceneContinue Reading

Illinois officials authorized 26 businesses to provide health and safety training to recreational marijuana retailers, including existing medical cannabis operators, in advance of the adult-use program launch on Jan. 1. The Department of Financial and Professional Regulation announced the list of “responsible vendors.” A statement from the agency said “atContinue Reading

Due to the highly fragmented legal and regulatory landscape of the cannabis industry, the sources from which a company generates revenues can have a huge impact on a company’s opportunity and risk profile. Look beyond customer count to assess marijuana revenue concentration is a post from: Marijuana Business Daily: Financial,Continue Reading

Hundreds of people across the country have taken ill over the past weeks with a severe pulmonary affliction apparently linked to the vaping of cannabis products and nicotine-filled e-cigarettes. The victims are now said to number over 450 — and many were otherwise healthy young people, in their teens orContinue Reading

Alberta-based Aurora Cannabis reported net revenue of 99 million Canadian dollars ($75 million) in its most recent quarter, a 418% increase from CA$19 million in the same quarter last year. However,  international sales amounted to only CA$4 million in Aurora’s fiscal fourth quarter, which ended June 30. Aurora saw improvementsContinue Reading